Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 885

1.

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.

Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML; METEOR Study Group.

JAMA. 2007 Mar 28;297(12):1344-53. Epub 2007 Mar 25.

PMID:
17384434
2.

Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.

Crouse JR 3rd, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS; METEOR Study Group.

Eur J Cardiovasc Prev Rehabil. 2010 Apr;17(2):223-9. doi: 10.1097/HJR.0b013e3283359c38.

PMID:
20038840
3.

Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.

Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, O'Leary DH, Grobbee DE, Crouse JR 3rd; METEOR Study Group.

J Intern Med. 2009 Jun;265(6):698-707. doi: 10.1111/j.1365-2796.2009.02073.x. Epub 2009 Mar 2.

4.

C-reactive protein lowering with rosuvastatin in the METEOR study.

Peters SA, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Raichlen JS, Bots ML.

J Intern Med. 2010 Aug;268(2):155-61. doi: 10.1111/j.1365-2796.2010.02230.x. Epub 2010 Mar 6.

5.
6.

Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.

Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Lind L, Bots ML; METEOR Study Group.

J Intern Med. 2012 Mar;271(3):247-56. doi: 10.1111/j.1365-2796.2011.02422.x. Epub 2011 Aug 11.

7.

Prevention of atherosclerosis in patients living with HIV.

De Lorenzo F, Boffito M, Collot-Teixeira S, Gazzard B, McGregor JL, Shotliff K, Xiao H.

Vasc Health Risk Manag. 2009;5(1):287-300. Epub 2009 Apr 8.

8.

Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.

Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Investigators.

J Am Soc Echocardiogr. 2012 Jan;25(1):91-100. doi: 10.1016/j.echo.2011.09.009. Epub 2011 Oct 7.

PMID:
21982737
9.

The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.

Peters SA, Dogan S, Meijer R, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML.

J Atheroscler Thromb. 2011;18(9):784-95. Epub 2011 May 27.

10.

Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.

Crouse JR 3rd, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; METEOR Study Group.

Curr Med Res Opin. 2007 Mar;23(3):641-8.

PMID:
17355745
11.

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators.

JAMA. 2006 Apr 5;295(13):1556-65. Epub 2006 Mar 13.

PMID:
16533939
12.

Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.

Crouse JR 3rd, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS; Measuring Effects on intima media Thickness: an Evalution Of Rosuvastatin study group.

Cardiovasc Drugs Ther. 2004 May;18(3):231-8.

PMID:
15229392
13.

Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.

Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Group.

Curr Med Res Opin. 2012 Jun;28(6):891-9. doi: 10.1185/03007995.2012.689255. Epub 2012 Jun 6.

PMID:
22536884
14.

Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.

Dogan S, Plantinga Y, Crouse JR 3rd, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML; METEOR Study Group.

J Hypertens. 2011 Nov;29(11):2181-93. doi: 10.1097/HJH.0b013e32834b0eba.

PMID:
21918474
15.

Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study.

Riccioni G, Bazzano LA, Bucciarelli T, Mancini B, di Ilio E, D'Orazio N.

Expert Opin Pharmacother. 2008 Oct;9(14):2403-8. doi: 10.1517/14656566.9.14.2403 .

PMID:
18778179
16.

Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.

Tam LS, Li EK, Shang Q, Tomlinson B, Lee VW, Lee KK, Li M, Kuan WP, Li TK, Tseung L, Yip GW, Freedman B, Yu CM.

Scand J Rheumatol. 2011 Nov;40(6):411-21. doi: 10.3109/03009742.2011.586649. Epub 2011 Aug 26.

PMID:
21867445
17.
18.

Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials.

Bedi US, Singh M, Singh PP, Bhuriya R, Bahekar A, Molnar J, Khosla S, Arora R.

J Cardiovasc Pharmacol Ther. 2010 Sep;15(3):268-73. doi: 10.1177/1074248410369110. Epub 2010 May 14.

PMID:
20472815
19.

Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.

Lind L, Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Group.

J Am Soc Echocardiogr. 2012 Oct;25(10):1120-1127.e1. doi: 10.1016/j.echo.2012.07.004. Epub 2012 Aug 9.

PMID:
22884641
20.

Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.

Riccioni G, Cipollone F, Santovito D, Scotti L, D'Orazio N, Mezzetti A, Bucciarelli T.

Expert Opin Pharmacother. 2011 Dec;12(17):2599-604. doi: 10.1517/14656566.2011.618497. Epub 2011 Oct 15.

PMID:
21999752

Supplemental Content

Support Center